rezvilutamide,bicalutamide
astrazeneca,jiangsu hengrui pharmaceuticals
[]
a phase 3 trial of shr3680 vs bicalutamide in combination with adt in patients with high-volume #mhspc. presented by ding-wei ye, md, phd. #asco22 written coverage by on urotoday &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology